Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0086543 (
cataract
)
29,165
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
DM1 (myotonic dystrophy type 1) is caused by elongation of a CTG repeat in the DMPK (dystrophia myotonica-protein kinase) gene. mRNA transcripts containing these CUGexp (CUG expansion) repeats form accumulations, or foci, in the nucleus of the cell. The pathogenesis of DM1 is proposed to result from inappropriate patterns of alternative splicing caused by sequestration of the developmentally regulated alternative splicing factor
MBNL1
(muscleblind-like 1) by these foci. Since eye lens
cataract
is a common feature of DM1 we have examined the distribution and dynamics of
MBNL1
in lens epithelial cell lines derived from patients with DM1. The results of the present study demonstrate that only a small proportion of nuclear
MBNL1
accumulates in CUGexp pre-mRNA foci.
MBNL1
is, however, highly mobile and changes localization in response to altered transcription and splicing activity. Moreover, immunolocalization studies in lens sections suggest that a change in
MBNL1
distribution is important during lens growth and differentiation. Although these data suggest that the loss of
MBNL1
function due to accumulation in foci is an unlikely explanation for DM1 symptoms in the lens, they do demonstrate a strong relationship between the subcellular
MBNL1
localization and pathways of cellular differentiation, providing an insight into the sensitivity of the lens to changes in
MBNL1
distribution.
...
PMID:Transcriptionally correlated subcellular dynamics of MBNL1 during lens development and their implication for the molecular pathology of myotonic dystrophy type 1. 2435 50